ArticleOphthalmology and therapy2019

The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema.

Alexander Eaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.